# Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

> **NCT05602974** · NA · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 140 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Narrow Margin
- Adjuvant Stereotactic Body Radiotherapy
- Hepatectomy

## Interventions

- **RADIATION:** stereotactic body radiation therapy
- **OTHER:** regular follow-up

## Key facts

- **NCT ID:** NCT05602974
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05602974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05602974, "Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05602974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*